Add To Watchlist
Share URL
About The Company
CEO
Mr. Diggory William Howitt BE (Hons), MBA
Market Cap
9.96 Billion USD
Sector
Healthcare
Website
https://www.cochlear.comDescription
Cochlear Limited provides implantable hearing solutions for adults and children worldwide.
Read More
Overview
Value
0
Growth
20
Health
0
Management
0
Analyst Opinion
0
Total
20
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Has a low level of debt
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Poor overall financial health
- Poor earnings and cashflow growth
Latest News
Amazon Fire TV devices can now directly stream audio to Cochlear hearing implants
TechCrunch | 13:30 Wed 22 Feb 2023
Read More →
Cochlear Limited (CHEOF) Q2 2023 Earnings Call Transcript
Seeking Alpha | 15:16 Wed 15 Feb 2023
Read More →
Cochlear Limited (CHEOF) CEO Dig Howitt on Q4 2022 Results - Earnings Call Transcript
Seeking Alpha | 10:38 Fri 19 Aug 2022
Read More →
Cochlear expects more uncertainty due to operating room constraints: CEO
CNBC International TV | 04:51 Tue 22 Feb 2022
Read More →
Market Peers
CHEOY
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
N/A
Revenue Growth (5 Year Average)
N/A
Ratings Consensus
N/A
Share Buybacks
N/A
Dividend Yeild (TTM)
N/A
Valuation
Value Score
0
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 12.8 USD ✘
Current Price: 76.1 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
N/A
PE/Earnings Growth
N/A
Price/Book
5.94x
Growth
Growth Score
20
- ✔ Revenue growth has improved this yeara
- ✔ Earnings growth has improved this year
- ✔ Free Cashflow growth has improved this year
- ✘ 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
- ✘ 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
- ✘ 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
Revenue Growth
N/A
Earnings Growth
N/A
Cashflow Growth
N/A
Health
Health Score
0
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
0.15x
Current Assets/Liabilities
2.52x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.19x
Management
Management Score
0
Average Buybacks/Dilution
N/A
Recent Buybacks/Dilution
N/A
5 Year Price Volitility
12.09%
Return On Assets
N/A
Return On Capital Employed
N/A
Return On Equity
N/A
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
0
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Currency
USD
Beta
Vol Avg
Ceo
Mr. Diggory William Howitt BE (Hons), MBA
Cik
Cusip
191459205
Exchange
Other OTC
Full Time Employees
Industry
Medical Devices
Sector
Healthcare
Ipo Date
Address
1 University Avenue
City
Sydney
State
NSW
Country
Zip
2109
Phone
61 2 9428 6555
All financial data provided by FMP